CVE:KLH - Stellar Biotechnologies Stock Price, News, & Analysis

eye icon Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average Volume5,576 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Stellar Biotechnologies, Inc. is a biotechnology company. The Company is engaged in the aquaculture, research and development, manufacture and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a range of diseases. The Company's core business is developing and commercializing Keyhole Limpet Hemocyanin for use in immunotherapy and immunodiagnostic applications. The Company's Stellar KLH product offerings include Stellar KLH protein for conjugation and as carrier molecule in immunotherapy development; Stellar KLH protein and enzyme-linked immunosorbent assay (ELISA) test kits for immune function testing, and Custom KLH formulations, adjuvants, conjugations and fill finishes for preclinical research and drug development applications.

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive KLH News and Ratings via Email

Sign-up to receive the latest news and ratings for KLH and its competitors with MarketBeat's FREE daily newsletter.

Stellar Biotechnologies (CVE:KLH) Frequently Asked Questions

What is Stellar Biotechnologies' stock symbol?

Stellar Biotechnologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KLH."

Has Stellar Biotechnologies been receiving favorable news coverage?

News articles about KLH stock have trended somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Stellar Biotechnologies earned a news impact score of 1.2 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Stellar Biotechnologies.

What other stocks do shareholders of Stellar Biotechnologies own?

How do I buy shares of Stellar Biotechnologies?

Shares of KLH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Stellar Biotechnologies' official website?

The official website for Stellar Biotechnologies is

How can I contact Stellar Biotechnologies?

Stellar Biotechnologies' mailing address is 332 E Scott St, PORT HUENEME, CA 93041-2939, United States. The biotechnology company can be reached via phone at +1-805-4882800.

MarketBeat Community Rating for Stellar Biotechnologies (CVE KLH)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  50 (Thanks for Voting!)
Underperform Votes:  59 (Thanks for Voting!)
Total Votes:  109
MarketBeat's community ratings are surveys of what our community members think about Stellar Biotechnologies and other stocks. Vote "Outperform" if you believe KLH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KLH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel